Tumor tissue based biomarkers for bevacizumab combination therapies

Details for Australian Patent Application No. 2011208805 (hide)

Owner F. Hoffman-La Roche AG

Inventors Delmar, Paul; Foernzler, Dorothee; Scherer, Stefan

Agent Griffith Hack

Pub. Number AU-A-2011208805

PCT Pub. Number WO2011/089101

Priority 10151109.5 19.01.10 EP

Filing date 18 January 2011

Wipo publication date 28 July 2011

International Classifications

A61K 39/395 Medicinal preparations containing antigens or antibodies - Antibodies

G01N 33/574 Investigating or analysing materials by specific methods not covered by groups - for cancer

Event Publications

21 June 2012 PCT application entered the National Phase

  PCT publication WO2011/089101 Priority application(s): WO2011/089101

Legal

The information provided by the Site not in the nature of legal or other professional advice. The information provided by the Site is derived from third parties and may contain errors. You must make your own enquiries and seek independent advice from the relevant industry professionals before acting or relying on any information contained herein. Check the above data against the Australian Patent Office AUSPAT database.

Next and Previous Patents/Applications

2011208809-A method for controlling arthropods comprising the spot-wise application of a gel

2011208780-Concrete spraying method using heat recovery